<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did Journey Medical's revenue and expenses trend in Q4 2024 compared to previous quarters?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/9/2025 04:41am
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Journey Medical's revenue and expenses for Q4 2024 are as follows:




In Q4 2024, Journey Medical's revenue increased by approximately $13.62 million compared to the previous quarter (Q3 2024), while the expenses remained relatively stable. This trend indicates a significant improvement in the company's financial performance during the period, primarily driven by the increase in revenue.</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai){return {layout:"default",data:[{noData:c,currentQuestion:e,textDescription:I,comeFrom:"AInvestShareLink",events:[],answerSource:m}],fetch:{},error:n,state:{sharePreviewModule:{loadJgySuccess:f,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:o,agent_id:a,output_media_info:[],task_id:a,language:a,source:m,cache_builder:a,reply_action:"Answer",execute_mode:B,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did Journey Medical's revenue and expenses trend in Q4 2024 compared to previous quarters?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did Journey Medical's revenue and expenses trend in Q4 2024 compared to previous quarters?\",\"user_id\":\"dp13116093\",\"user_name\":\"\",\"trace_id\":\"f7f931f1-3de1-4b66-842e-bfed55ea5109\",\"session_id\":\"f7f931f1-3de1-4b66-842e-bfed55ea5109\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:C,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Total Revenue (Cum)[20241231]|Total Expenses (Cum)[20241231]|Report End Date|\n|---|---|---|---|---|---|---|\n|DERM|Journey Medical|$6.88|-1.01%|$56.13 million||20241231|\n",query_data:{number:o,title:D,query_type:C,condition:a,model_sql:J,data_ext_params:{merge_repeat:c,expand_index:b,data_add:o,add_index:f}}}],answer_chain_name:K,agent_mode:L,native_answer:a,come_from:a,text_answer:I,trace_id:j,cost:15450,event_names:a,question:e,fallback_type:M,input_type:N,fall_back_reason:{fall_back_type:M,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:j,first_return_cost:5776,cache_type:"no_cache",question_id:j,transfer_question:e,signal_type:"ON_COMPLETE",start_time:E,remote_svc:m,slots:[],answer_type:B,user_id:x,skill_name:F},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:j,session_id:j,user_id:x,question:e,source:m,raw_question:e,version:"3.4.1",action_name:F,nlu:{entity:[{type:O,value:"DERM.O",market:P}]},output_time:E,deep_research:c,deep_thinking:c,agent_mode:L},extra:{}},{answer_path:g,section:{id:h,info_texts:["Thinking"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:g,section:{id:h,info_texts:["Querying Stock: DERM Revenue (FY), Expenses (FY) in Q4 2024"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:p},logs:[],extra:{action:q,action_input:D,thought:r}},{answer_path:g,section:{id:h,info_texts:["Querying Stock: DERM Revenue (FY), Expenses (FY) in Q3 2024"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:p},logs:[],extra:{action:q,action_input:"DERM Revenue (FY), Expenses (FY) in Q3 2024",thought:r}},{answer_path:g,section:{id:h,info_texts:["Querying Stock: DERM Revenue (FY), Expenses (FY) in Q2 2024"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:p},logs:[],extra:{action:q,action_input:"DERM Revenue (FY), Expenses (FY) in Q2 2024",thought:r}},{answer_path:g,section:{id:h,info_texts:["Querying Stock: DERM Revenue (FY), Expenses (FY) in Q1 2024"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:p},logs:[],extra:{action:q,action_input:"DERM Revenue (FY), Expenses (FY) in Q1 2024",thought:r}},{answer_path:g,section:{id:h,info_texts:["Querying Stock: DERM Revenue (FY), Expenses (FY) in Q4 2019"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:p},logs:[],extra:{action:q,action_input:"DERM Revenue (FY), Expenses (FY) in Q4 2019",thought:r}},{answer_path:d,section:{id:s,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:g,section:{id:h,info_texts:["Generating Answer"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:y,info_texts:[],show_type:z,voice_txt:"J",text_answer:Q,rich_text:Q,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:z,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:D,query_type:C,trace_data:a,index:o,model_sql:J,data_ext_params:{merge_repeat:c,expand_index:b,data_add:o,add_index:f},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:y,info_texts:[],show_type:z,voice_txt:":\n\n",text_answer:R,rich_text:R,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"DERM",market_id:P,name:S,domain:O},pos:f,section_id:y,txt:S,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:y,info_texts:[],show_type:z,voice_txt:"In",text_answer:T,rich_text:T,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:g,section:{id:h,info_texts:["Completed"],show_type:i,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:t,query_text:t,trace_info:{item_id:"7ea20f1a0cb491ce73c38f81d0536ef5",item_type:l,item_name:t,rec_info:U}},{display_text:u,query_text:u,trace_info:{item_id:"1814c0b9f1da6fb4eaf2fbd6f2362eea",item_type:l,item_name:u,rec_info:V}},{display_text:v,query_text:v,trace_info:{item_id:"d3b65699be408dac0f8dc41270423e0a",item_type:l,item_name:v,rec_info:W}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:c,txt_style:f,type:"1",display2:c,url:a}},request_config:[{source_type:X,related_name:Y}],puuid:G,tag:a,category:"custom",uuid:Z}],global:{urp_static_data:[{name:Y,value:{status_code:f,columns:[{type:w,index_name:_,key:_},{type:w,index_name:$,key:$},{type:w,index_name:aa,key:aa},{type:w,index_name:ab,key:ab},{type:w,index_name:ac,key:ac}],datas:[{send_text:t,item_type:l,rec_info:U,display_text:t,rec_reason:a},{send_text:u,item_type:l,rec_info:V,display_text:u,rec_reason:a},{send_text:v,item_type:l,rec_info:W,display_text:v,rec_reason:a}],dataSize:X,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:ad,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:A,"min-height":"100%",position:ae,height:A},isMaterial:c,id:ad,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:f,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:H,componentUuid:Z,script:[{name:af,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:H,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:H},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:A,position:ae,height:A},isMaterial:b,_id:19,id:af,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:ag,voice_txt:a,tracking_info:{},uuid:G},order:{is_auto:c,render_for:ag,chart_type:"command",puuid:G}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:F,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:B,answer_chain_name:K},is_deep_research:c,deep_thinking:c,create_time:1746736894295},is_last:b}],questionItem:{data:{qStr:e,encodeFlag:c,imageData:n,docsData:[],quoteData:n},tplType:"question"},events:ah,agentId:a,param:{entity_info:{},add_info:{ori_question:e},event_list:ah,client_ip:a,question:e,user_id:x,user_name:a,trace_id:j,session_id:j,source:m,input_type:N}}],userId:x,userName:a,startTime:E,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:n,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:f,traceTableData:n,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-journey-medicals-revenue-and-expenses-trend-in-q4-2024-compared-to-previous-quarters-cb7583\u002F",config:{_app:{basePath:ai,assetsPath:ai,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer","How did Journey Medical's revenue and expenses trend in Q4 2024 compared to previous quarters?",0,"progress\u002Fsearching_for",1000,"searching_for","f7f931f1-3de1-4b66-842e-bfed55ea5109","signal","llm_generated","ths_ainvest_lite_web",null,1,"thinking","Querying Stock","The user wants to compare the revenue and expense performance of Journey Medical in Q4 2024 with previous quarters. I should focus on the revenue and expense data of Q4 2024 and the previous quarter(s). I will use FinQuery to obtain the revenue and expense data of Q4 2024 and the previous quarter(s) for the past five years.",999,"🚀 What was Journey Medical's net income in Q4 2024?","📈 What were Journey Medical's revenue figures for Q4 2024?","💰 What are the key factors driving Journey Medical's revenue growth in Q4 2024?","STR","dp13116093",2001,"rich_text","auto","agent","intusstock","DERM Revenue (FY), Expenses (FY) in Q4 2024",1746736878845,"inspect stocks","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Journey Medical's revenue and expenses for Q4 2024 are as follows:\n\n\n\n\nIn Q4 2024, Journey Medical's revenue increased by approximately $13.62 million compared to the previous quarter (Q3 2024), while the expenses remained relatively stable. This trend indicates a significant improvement in the company's financial performance during the period, primarily driven by the increase in revenue.","select   stock_code,   total_revenue_cum,   total_expenses_cum from   ustock_fin_data where   report_end_date = date('2024y4q')   and stock_code = 'DERM.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","186","Journey Medical's revenue and expenses for Q4 2024 are as follows[^1]",":\n\n\n``` visual\n{\"uuid\":\"7efcdccc-5e15-4fdc-adb5-e56d3ae5b710\"}\n```\n\n","Journey Medical","In Q4 2024, Journey Medical's revenue increased by approximately $13.62 million compared to the previous quarter (Q3 2024), while the expenses remained relatively stable. This trend indicates a significant improvement in the company's financial performance during the period, primarily driven by the increase in revenue.","2+679_496_21_554+0+0+f7f931f1-3de1-4b66-842e-bfed55ea5109+7ea20f1a0cb491ce73c38f81d0536ef5+llm_generated+aimeTagAnalysis+0+0.020300354808568954+1","2+679_496_21_554+0+0+f7f931f1-3de1-4b66-842e-bfed55ea5109+1814c0b9f1da6fb4eaf2fbd6f2362eea+llm_generated+aimeTagAnalysis+0+0.016937335953116417+2","2+679_496_21_554+0+0+f7f931f1-3de1-4b66-842e-bfed55ea5109+d3b65699be408dac0f8dc41270423e0a+llm_generated+aimeTagAnalysis+0+0.006583356764167547+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>